Navigation Links
Additional Data on CombinatoRx Drug Candidates CRx-102 and CRx-139,Presented at EULAR

ials of its product candidates, the Company's ability to develop a modified release formulation of CRx-102, potential difficulty and delays in obtaining regulatory approval for the sale and marketing of its product candidates, the Company's ability to obtain additional financing or funding for its research and development and those other risks that can be found in the "Risk Factors" section of the CombinatoRx Annual Report on Form 10-K on file with the Securities and Exchange Commission and the other reports that CombinatoRx periodically files with the Securities and Exchange Commission. Actual results may differ materially from those CombinatoRx contemplated by these forward-looking statements. CombinatoRx does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this release.

(c) 2007 CombinatoRx, Incorporated. All rights reserved.

Contact

CombinatoRx, Incorporated
Robert Forrester, 617-301-7100
EVP, Chief Financial Officer
rforrester@combinatorx.com
or
Gina Nugent, 617-301-7099
VP, Corporate Communications and IR
gnugent@combinatorx.com


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
2. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
3. Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits
4. Novel Mechanism Insights and Additional Data on CombinatoRx Drug Candidates to Be Presented at Upcoming EULAR Meeting
5. Elixir Pharmaceuticals Presents Additional Preclinical Data Demonstrating the Potential of Ghrelin Antagonism to Regulate Metabolism, Body Weight and Glycemic Control
6. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
7. Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer
8. Additional New Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at ASCO Annual Meeting
9. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
10. Additional Efficacy Data from Satraplatin SPARC Phase 3 Investigational Trial Presented at Annual Meeting of American Urological Association
11. PTC Therapeutics Announces Additional Positive Interim Phase 2 Results of PTC124 in Duchenne Muscular Dystrophy
Post Your Comments:
(Date:7/29/2015)... , July 29, 2015 Dignity Health Saint ... Institute, combining the services of the hospital,s former Total ... centralized location, and expanding services to include shoulder orthopedic ... from Saint Francis Memorial Hospital at 1199 Bush Street. ... a premier center aimed at providing a continuum of ...
(Date:7/29/2015)... July 29, 2015  Nektar Therapeutics (Nasdaq: NKTR ) ... June 30, 2015 on Wednesday, August 5, 2015, after the ... and chief executive officer, will host a conference call to ... p.m. Pacific Time (PT). The press release ... be accessed through a link that is posted on the ...
(Date:7/29/2015)... CAMBRIDGE, Mass. , July 29, ... ), the leader in RNA-targeted therapeutics, and Akcea ... The New England Journal of Medicine ... study evaluating volanesorsen (formerly ISIS-APOCIII Rx ) in ... This publication follows the December 2014 publication in ...
Breaking Medicine Technology:Saint Francis Memorial Hospital Orthopedic Institute Offers Comprehensive Orthopedic Care in One Location 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 2Nektar to Announce Financial Results for the Second Quarter 2015 on Wednesday, August 5, 2015, After Close of U.S.-Based Financial Markets 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7
... 20 Endo Pharmaceuticals (Nasdaq: ENDP ) will ... 2010 and will host a conference call and webcast at ... David P. Holveck, president and CEO of Endo, ... president of R&D, Alan Levin, executive vice president and chief ...
... and SYDNEY, Oct. 20 HeartWare International, Inc. (Nasdaq: ... third quarter and nine months ended September 30, 2010 prior ... November 3, 2010. A conference call with management ... Wednesday, November 3, 2010 (11:00 pm Australian Eastern Daylight Time ...
Cached Medicine Technology:Endo Pharmaceuticals to Announce Third Quarter 2010 Financial Results on November 1, 2010 2HeartWare to Report Financial Results for Third Quarter of 2010 2
(Date:7/30/2015)... ... July 30, 2015 , ... ... multinational organizations and NGO’s, according to a new survey by leading international insurance ... property damage and employee medical expenses represented the largest sources of financial losses ...
(Date:7/30/2015)... ... 30, 2015 , ... HEALTHCAREfirst , the leading provider of cloud-based software, ... is hosting a free webinar detailing the 2016 proposed rule from CMS for home ... Vice President of Regulatory Affairs for the National Association for Home Care and Hospice ...
(Date:7/30/2015)... ... July 30, 2015 , ... Case Mason ... services for consumer brands, recently completed a consolidation of all of its production ... company operated out of two separate locations situated 11 miles apart. , The ...
(Date:7/29/2015)... Illinois (PRWEB) , ... July 30, 2015 , ... ... receive orthodontic scholarships through the Smile for a Lifetime program by encouraging their clients ... idea was created by MWM Presidents Dr. Mart McClellan and Tim Streid, who see ...
(Date:7/29/2015)... ... , ... According to data released today by the Centers for Medicare & ... stable at $32.50, a figure far lower than was originally projected, the Pharmaceutical Care ... bright spot in American health care. By offering an abundance of competing choices in ...
Breaking Medicine News(10 mins):Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 2Health News:New Clements Worldwide Global Risk Survey Shows Political Risk and Instability Top Managers' Concerns 3Health News:HEALTHCAREfirst Announces Home Health Industry Regulatory Review Webinar 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2
... Medicare Claims Denials by 50% and IVANS LIME Is Ten Times ... ... 18, 2009 -- IVANS , the leading provider of corporate ... Verification solution has helped Mobile X-Ray Imaging Inc. significantly reduce ...
... DALLAS, Feb. 18 Every week more than 3,000 people in ... many find themselves with insufficient coverage or lack of insurance to ... , , The Limbs for Life Foundation ... and provide them with financial assistance to return to productive jobs ...
... their meat. Whether it,s rib eyes, pork chops or chicken ... country that more than 85 billion pounds of meat and ... a quarter of U.S. beef and pork is exported to ... the world,s largest consumer of meat, in Mexico, meat consumption ...
... pressure medication may be the key to preventing brain ... newly published study by researchers at Wake Forest University ... of an improved quality of life for cancer patients. ... a hypothesis from previous studies that a compound similar ...
... , A research group of the Universities of Granada ... food craving, an irresistible desire for eating certain foods (sweets, ... out by Professors Silvia Moreno Domnguez (University of ... and M Carmen Fernndez-Santaella ( University of Granada ...
... by Cop" (SBC) is a suicide method in which a ... an attempt to get oneself killed or injured by law ... Sciences examined the prevalence of this phenomenon among a ... SBC occurs at extremely high rates, with 36 percent of ...
Cached Medicine News:Health News:IVANS Helps Mobile X-Ray Imaging Inc. Reduce Its Costs for Uncompensated Care 2Health News:IVANS Helps Mobile X-Ray Imaging Inc. Reduce Its Costs for Uncompensated Care 3Health News:Limbs for Life Foundation to Host 8th Annual Fundraiser and Live Auction 2Health News:American Veterinary Medical Association: Weaving a Web for Food Safety 2Health News:Blood pressure compound may benefit brain tumor patients 2Health News:Blood pressure compound may benefit brain tumor patients 3Health News:Several studies prove self-banning certain foods may cause food craving 2Health News:'Suicide by cop' phenomenon occurring in over a third of North American shootings involving police 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: